Biotech entity
pharma is the sole category represented across all 1 tracked stories. FulcrumSec is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. We currently track 1 Biotech story that mention Lab-1, all published on June 17, 2026.
Last mentioned: Jun 17, 2026
Entity pulse
Coverage balance Negative coverage leads. Negative coverage exceeds positive coverage by 100 percentage points.
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
pharma is the sole category represented across all 1 tracked stories. FulcrumSec is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. We currently track 1 Biotech story that mention Lab-1, all published on June 17, 2026. Each carries 2 original sources on average.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 1 Biotech stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Lab-1. Shared-story counts are live from our verified record — not editorial picks.
FulcrumSec's breach of Novo Nordisk could jeopardize years of R&D as stolen data includes proprietary information on released and unreleased drugs, trial data, and manufacturing processes. With the extortion failure and potential data sale, rival pharma firms may gain competitive intelligence, threatening Novo's market position.
Lab-1 is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
